Teva Pharmaceutical Industries Limited (TEVA) Announced Q1 2026 Earnings on April 29, 2026, Reporting "Our Q1 revenue were approximately $4 billion".
Teva Pharmaceutical Industries reported Q1 2026 earnings with $4 billion in revenue, $360 million in net income, and $0.53 non-GAAP EPS. The company discussed the acquisition of Emalex Biosciences and provided updates on its AUSTEDO and UZEDY revenues, generics pipeline, and…